These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 10519392)
21. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts. Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804 [TBL] [Abstract][Full Text] [Related]
22. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Shibutani S; Ravindernath A; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML Carcinogenesis; 2000 Aug; 21(8):1461-7. PubMed ID: 10910945 [TBL] [Abstract][Full Text] [Related]
24. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Randerath K; Moorthy B; Mabon N; Sriram P Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037 [TBL] [Abstract][Full Text] [Related]
26. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling. Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009 [TBL] [Abstract][Full Text] [Related]
27. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen. Dasaradhi L; Shibutani S Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430 [TBL] [Abstract][Full Text] [Related]
28. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473 [TBL] [Abstract][Full Text] [Related]
29. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618 [TBL] [Abstract][Full Text] [Related]
30. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. Eder E; Schuler D; Budiawan IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223 [TBL] [Abstract][Full Text] [Related]
31. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers. Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924 [TBL] [Abstract][Full Text] [Related]
32. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471 [TBL] [Abstract][Full Text] [Related]
33. Identification of the major hepatic DNA adduct formed by the food mutagen 2-amino-9H-pyrido[2,3-b]indole (A alpha C). Pfau W; Schulze C; Shirai T; Hasegawa R; Brockstedt U Chem Res Toxicol; 1997 Oct; 10(10):1192-7. PubMed ID: 9348443 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts. Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898 [TBL] [Abstract][Full Text] [Related]
35. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis. Reddy MV; Irvin TR; Randerath K Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087 [TBL] [Abstract][Full Text] [Related]
36. Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). Schoket B; Doty WA; Vincze I; Strickland PT; Ferri GM; Assennato G; Poirier MC Cancer Epidemiol Biomarkers Prev; 1993; 2(4):349-53. PubMed ID: 8348058 [TBL] [Abstract][Full Text] [Related]
37. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction. Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433 [TBL] [Abstract][Full Text] [Related]
38. Formation and persistence of novel benzo(a)pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA. Ross J; Nelson G; Kligerman A; Erexson G; Bryant M; Earley K; Gupta R; Nesnow S Cancer Res; 1990 Aug; 50(16):5088-94. PubMed ID: 2199033 [TBL] [Abstract][Full Text] [Related]
39. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535 [TBL] [Abstract][Full Text] [Related]
40. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells. McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]